GradedCalls Analysts
Loading the ledger…
GradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
Pfizer · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 1Y
—/100Average of active call grades
GC score—/10GC 1→GC 10
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
0
In this factor
Superseded
3
Visible, not scored
Hit rate
—
No graded calls for this horizon.
History only. A later call on the same ticker within 90 days replaced these. The notes stay. They do not enter the overall factor.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 Nullified Nullified — superseded by later call on Oct 8, 2026 (within 90 days). Later call | Akash TewariJefferies | Target raise Desk rating stays Buy | Buy | — | — | Not scored | ||
Active calls only
If followed
—
Active directional calls
No active graded calls in this window yet.
Nullified — superseded by later call on Oct 8, 2026 (within 90 days). Later call
| Chris SchottJPMorgan |
| Maintain Neutral Desk rating stays Neutral |
| Hold |
| — |
| — |
Not scored |
| Jul 6, 2026 Nullified Nullified — superseded by later call on Sep 10, 2026 (within 90 days). Later call | Rajesh KumarHSBC | Downgrade to Hold Desk rating Buy → Hold | Hold | — | — | Not scored |